163 related articles for article (PubMed ID: 32426967)
1. Quantitative Analysis of α-1-Antitrypsin Glycosylation Isoforms in HCC Patients Using LC-HCD-PRM-MS.
Yin H; Zhu J; Wang M; Yao ZP; Lubman DM
Anal Chem; 2020 Jun; 92(12):8201-8208. PubMed ID: 32426967
[TBL] [Abstract][Full Text] [Related]
2. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
3. The analysis of alpha-1-antitrypsin glycosylation with direct LC-MS/MS.
Yin H; An M; So PK; Wong MY; Lubman DM; Yao Z
Electrophoresis; 2018 Sep; 39(18):2351-2361. PubMed ID: 29405331
[TBL] [Abstract][Full Text] [Related]
4. A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.
Lin Y; Zhu J; Pan L; Zhang J; Tan Z; Olivares J; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2021 Jun; 20(6):3278-3289. PubMed ID: 33929864
[TBL] [Abstract][Full Text] [Related]
5. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.
Yuan W; Sanda M; Wu J; Koomen J; Goldman R
J Proteomics; 2015 Feb; 116():24-33. PubMed ID: 25582524
[TBL] [Abstract][Full Text] [Related]
7. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry.
Chen Y; Snyder MR; Zhu Y; Tostrud LJ; Benson LM; Katzmann JA; Bergen HR
Clin Chem; 2011 Aug; 57(8):1161-8. PubMed ID: 21636698
[TBL] [Abstract][Full Text] [Related]
9. Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis.
Zhu J; Huang J; Zhang J; Chen Z; Lin Y; Grigorean G; Li L; Liu S; Singal AG; Parikh ND; Lubman DM
J Proteome Res; 2020 Aug; 19(8):3452-3466. PubMed ID: 32412768
[TBL] [Abstract][Full Text] [Related]
10. Differential Quantitative Determination of Site-Specific Intact N-Glycopeptides in Serum Haptoglobin between Hepatocellular Carcinoma and Cirrhosis Using LC-EThcD-MS/MS.
Zhu J; Chen Z; Zhang J; An M; Wu J; Yu Q; Skilton SJ; Bern M; Ilker Sen K; Li L; Lubman DM
J Proteome Res; 2019 Jan; 18(1):359-371. PubMed ID: 30370771
[TBL] [Abstract][Full Text] [Related]
11. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
13. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
14. Large Scale Screening and Quantitative Analysis of Site-Specific N-Glycopeptides from Human Serum in Early Alzheimer's Disease Using LC-HCD-PRM-MS.
Pan L; Lin Y; Zhu J; Zhang J; Tan Z; Lubman DM
J Proteomics Bioinform; 2022; 15(5):. PubMed ID: 37362028
[TBL] [Abstract][Full Text] [Related]
15. PRM-MS Quantitative Analysis of Isomeric
Gutierrez Reyes CD; Huang Y; Atashi M; Zhang J; Zhu J; Liu S; Parikh ND; Singal AG; Dai J; Lubman DM; Mechref Y
Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436504
[TBL] [Abstract][Full Text] [Related]
16. A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation.
Lin Y; Zhang J; Arroyo A; Singal AG; Parikh ND; Lubman DM
Front Oncol; 2022; 12():818001. PubMed ID: 35372033
[TBL] [Abstract][Full Text] [Related]
17. In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation.
Hwang H; Lee JY; Lee HK; Park GW; Jeong HK; Moon MH; Kim JY; Yoo JS
Anal Bioanal Chem; 2014 Dec; 406(30):7999-8011. PubMed ID: 25374123
[TBL] [Abstract][Full Text] [Related]
18. Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of μTAS and parallel reaction monitoring.
Kim KH; Lee SY; Baek JH; Lee SY; Kim JY; Yoo JS
Proteomics Clin Appl; 2021 Jul; 15(4):e2000096. PubMed ID: 33764665
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
20. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P
J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
